The Boston startup uses AI to translate and verify legacy software for defense contractors, arguing modernization can’t come at the cost of new bugs.
Structure Therapeutics Inc. is emerging in oral GLP-1 obesity drugs after Phase II success and rivals’ setbacks. Click here ...
This study presents a potentially valuable exploration of the role of thalamic nuclei in language processing. The results will be of interest to researchers interested in the neurobiology of language.
The Yellow Ribbon Program is a provision of the Post-9/11 GI Bill that can help students attend expensive private schools at little or no cost to themselves. Normally, Post-9/11 GI Bill payments at ...
What's CODE SWITCH? It's the fearless conversations about race that you've been waiting for. Hosted by journalists of color, our podcast tackles the subject of race with empathy and humor. We explore ...
Nuclera and leadXpro partner to accelerate structure-based drug design for complex membrane proteins
Nuclera, the biotechnology company enabling rapid access to high-quality proteins and leadXpro, a specialist in structure-based drug discovery for membrane proteins, today announced a scientific ...
Structure-based drug design is the design and optimization of a chemical structure with the goal of identifying a compound suitable for clinical testing — a drug candidate. It is based on knowledge of ...
Metcalfe Park Community Bridges, a North Side nonprofit, is showcasing the power of resident-led action through its Reclaim ...
Optimizing Your LinkedIn Profile for Element Materials Technology So, you’re looking to make a splash at Element ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results